{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:37:01Z","timestamp":1707525421675},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,28]]},"DOI":"10.7759\/cureus.47884","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T22:31:56Z","timestamp":1698532316000},"source":"Crossref","is-referenced-by-count":0,"title":["Cryptococcal Pneumonia in a Patient on Tyrosine Kinase Inhibitor Therapy: How Common Is It?"],"prefix":"10.7759","author":[{"given":"Deny","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubani","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev K","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jof8111156","article-title":"Pulmonary cryptococcosis","volume":"8","author":"Howard-Jones AR","year":"2022","unstructured":"Howard-Jones AR, Sparks R, Pham D, Halliday C, Beardsley J, Chen SC. Pulmonary cryptococcosis. J Fungi (Basel). 2022, 8:1156. 10.3390\/jof8111156","journal-title":"J Fungi (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed B","year":"1995","unstructured":"Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995, 21:28-34; discussion 35-6. 10.1093\/clinids\/21.1.28","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.07.005","article-title":"Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis","volume":"50","author":"Brochard J","year":"2020","unstructured":"Brochard J, Morio F, Mahe J, et al.. Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis. Med Mal Infect. 2020, 50:742-5. 10.1016\/j.medmal.2020.07.005","journal-title":"Med Mal Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001-2010","volume":"20","author":"Bitar D","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, et al.. Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis. 2014, 20:1149-55. 10.3201\/eid2007.140087","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese T","year":"2018","unstructured":"Varughese T, Taur Y, Cohen N, Palomba ML, Seo SK, Hohl TM, Redelman-Sidi G. Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer. Clin Infect Dis. 2018, 67:687-92. 10.1093\/cid\/ciy175","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00265-13","article-title":"X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection","volume":"4","author":"Szymczak WA","year":"2013","unstructured":"Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. mBio. 2013, 4:","journal-title":"mBio"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164468-cryptococcal-pneumonia-in-a-patient-on-tyrosine-kinase-inhibitor-therapy-how-common-is-it","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:07Z","timestamp":1707509287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164468-cryptococcal-pneumonia-in-a-patient-on-tyrosine-kinase-inhibitor-therapy-how-common-is-it"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.47884","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,28]]}}}